Back to search
Staphylococcus Lugdunensis Infection
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Staphylococcus Lugdunensis Infection trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Staphylococcus Lugdunensis Infection trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
This is a single-patient, phase I/II clinical trial that aims to evaluate the potential of a bacteriophage drug product to treat and prevent the recurrence of a…
The main objective is to identify new virulence factors produced by Staphylococcus lugdunensis that can be associated with clinical sign of severe infections an…
Staphylococcus lugdunensis is a coagulase-negative staphylococcus belonging to the human commensal cutaneous flora, and has been little studied in the field of…
Staphylococcus lugdunensis is a coagulase-negative Staphylococcus (CoNS) belonging to the normal human skin flora. It is responsible for a wide variety of infec…